Bausch Health Companies Inc. (BHC.T) closed at C$27.47, up C$2.22 or 8.79%
— Highest close since Dec. 18, 2018, when it closed at C$28.16
— Largest percent increase since Sept. 12, 2018, when it rose 12.76%
— Earlier Wednesday, Piper Jaffray’s David Amsellem upgraded Bausch Health Companies to overweight and raised his price target to $27 from $22. “Though we have been unrelentingly negative on the company for years (at least up until a few months ago), we believe it is time to turn the page following a closer look at the business,” Amsellem said
— Down 92.07% from its all-time closing high of C$346.32 on Aug. 5, 2015
— Down 4.82% from 52 weeks ago (Jan. 3, 2018), when it closed at C$28.86
— Down 24.47% from its 52 week closing high of C$36.37 on Oct. 3, 2018
— Up 43.45% from its 52 week closing low of C$19.15 on March 2, 2018
— Traded as high as C$27.64; highest intraday level since Dec. 19, 2018, when it hit C$28.60
— Up 9.47% at today’s intraday high; largest intraday percent increase since Sept. 12, 2018, when it rose as much as 15.63%
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.